Table 3.
Correlations between CUDQ in caffeine consumers and their demographics and clinical characteristics.
| Characteristic | CUDQ | |
|---|---|---|
| (r) Coef. | P-value | |
| Age | −0.012 | 0.809 |
| BMI | −0.006 | 0.909 |
| Duration of primary headache disorder | −0.108 | 0.032* |
| MHD | 0.192 | <0.001* |
| AMD | 0.233 | <0.001* |
| HIT-6 total score | 0.201 | <0.001* |
| DASS-12 total score | 0.467 | <0.001* |
| SURPS total score | 0.438 | <0.001* |
AMD, acute medication days; BMI, body mass index; CUDQ, Caffeine Use Disorder Questionnaire; DASS-12, Depression Anxiety Stress Scales–12; HIT-6, Headache Impact Test-6; MHD, monthly headache days; SURPS, Substance Use Risk Profile Scale.
(r) Coef., Spearman correlation coefficient.
The p-values were adjusted for multiple testing using Benjamini and Hochberg procedure.
*p-value ≤ 0.032 is considered significant.